Cargando…

Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide

Self-nanoemulsifying drug delivery systems (SNEDDS) were used to enhance the dissolution rate of furosemide as a model for class IV drugs and the system was solidified into liquisolid tablets. SNEDDS of furosemide contained 10% Castor oil, 60% Cremophor EL, and 30% PEG 400. The mean droplets size wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalal, Lena, Allaf, Abdul Wahab, El-Zein, Hind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809212/
https://www.ncbi.nlm.nih.gov/pubmed/33446749
http://dx.doi.org/10.1038/s41598-020-79940-5
_version_ 1783637072539549696
author Dalal, Lena
Allaf, Abdul Wahab
El-Zein, Hind
author_facet Dalal, Lena
Allaf, Abdul Wahab
El-Zein, Hind
author_sort Dalal, Lena
collection PubMed
description Self-nanoemulsifying drug delivery systems (SNEDDS) were used to enhance the dissolution rate of furosemide as a model for class IV drugs and the system was solidified into liquisolid tablets. SNEDDS of furosemide contained 10% Castor oil, 60% Cremophor EL, and 30% PEG 400. The mean droplets size was 17.9 ± 4.5 nm. The theoretical model was used to calculate the amounts of the carrier (Avicel PH101) and coating materials (Aerosil 200) to prepare liquisolid powder. Carrier/coating materials ratio of 5/1 was used and Ludipress was added to the solid system, thus tablets with hardness of 45 ± 2 N were obtained. Liquisolid tablets showed 2-folds increase in drug release as compared to the generic tablets after 60 min in HCl 0.1 N using USP apparatus-II. Furosemide loaded SNEDDS tablets have great prospects for further in vivo studies, and the theoretical model is useful for calculating the adequate amounts of adsorbents required to solidify these systems.
format Online
Article
Text
id pubmed-7809212
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78092122021-01-15 Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide Dalal, Lena Allaf, Abdul Wahab El-Zein, Hind Sci Rep Article Self-nanoemulsifying drug delivery systems (SNEDDS) were used to enhance the dissolution rate of furosemide as a model for class IV drugs and the system was solidified into liquisolid tablets. SNEDDS of furosemide contained 10% Castor oil, 60% Cremophor EL, and 30% PEG 400. The mean droplets size was 17.9 ± 4.5 nm. The theoretical model was used to calculate the amounts of the carrier (Avicel PH101) and coating materials (Aerosil 200) to prepare liquisolid powder. Carrier/coating materials ratio of 5/1 was used and Ludipress was added to the solid system, thus tablets with hardness of 45 ± 2 N were obtained. Liquisolid tablets showed 2-folds increase in drug release as compared to the generic tablets after 60 min in HCl 0.1 N using USP apparatus-II. Furosemide loaded SNEDDS tablets have great prospects for further in vivo studies, and the theoretical model is useful for calculating the adequate amounts of adsorbents required to solidify these systems. Nature Publishing Group UK 2021-01-14 /pmc/articles/PMC7809212/ /pubmed/33446749 http://dx.doi.org/10.1038/s41598-020-79940-5 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Dalal, Lena
Allaf, Abdul Wahab
El-Zein, Hind
Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide
title Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide
title_full Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide
title_fullStr Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide
title_full_unstemmed Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide
title_short Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide
title_sort formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809212/
https://www.ncbi.nlm.nih.gov/pubmed/33446749
http://dx.doi.org/10.1038/s41598-020-79940-5
work_keys_str_mv AT dalallena formulationandinvitroevaluationofselfnanoemulsifyingliquisolidtabletsoffurosemide
AT allafabdulwahab formulationandinvitroevaluationofselfnanoemulsifyingliquisolidtabletsoffurosemide
AT elzeinhind formulationandinvitroevaluationofselfnanoemulsifyingliquisolidtabletsoffurosemide